- Home
- ZIMV vs TECH Comparison
ZIMV vs TECH Comparison
Compare ZIMV & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIMV
- TECH
- Stock Information
- Founded
- ZIMV 2021
- TECH 1976
- Country
- ZIMV United States
- TECH United States
- Employees
- ZIMV N/A
- TECH N/A
- Industry
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZIMV Health Care
- TECH Health Care
- Exchange
- ZIMV Nasdaq
- TECH Nasdaq
- Market Cap
- ZIMV 262.9M
- TECH 8.0B
- IPO Year
- ZIMV N/A
- TECH 1989
- Fundamental
- Price
- ZIMV $9.39
- TECH $48.10
- Analyst Decision
- ZIMV Hold
- TECH Buy
- Analyst Count
- ZIMV 1
- TECH 9
- Target Price
- ZIMV N/A
- TECH $81.25
- AVG Volume (30 Days)
- ZIMV 155.1K
- TECH 2.2M
- Earning Date
- ZIMV 05-07-2025
- TECH 05-07-2025
- Dividend Yield
- ZIMV N/A
- TECH 0.63%
- EPS Growth
- ZIMV N/A
- TECH N/A
- EPS
- ZIMV N/A
- TECH 0.98
- Revenue
- ZIMV $449,749,000.00
- TECH $1,196,016,000.00
- Revenue This Year
- ZIMV $1.90
- TECH $8.19
- Revenue Next Year
- ZIMV $2.61
- TECH $8.85
- P/E Ratio
- ZIMV N/A
- TECH $49.09
- Revenue Growth
- ZIMV N/A
- TECH 4.46
- 52 Week Low
- ZIMV $8.56
- TECH $46.44
- 52 Week High
- ZIMV $22.40
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- ZIMV 33.02
- TECH 33.97
- Support Level
- ZIMV $9.04
- TECH $46.44
- Resistance Level
- ZIMV $9.52
- TECH $53.00
- Average True Range (ATR)
- ZIMV 0.65
- TECH 3.30
- MACD
- ZIMV 0.02
- TECH -0.27
- Stochastic Oscillator
- ZIMV 35.39
- TECH 13.00
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.